Diabetes Drug Latest to Contain High Levels of Potential Carcinogen

A type 2 diabetes drug called metformin is the latest medication that was discovered to contain high levels of NDMA, a contaminant that’s a potential carcinogen. The substance was also found in multiple types of valsartan, a blood pressure medication, and both name brand and generic versions of Zantac, also known as ranitidine.

A test conducted by online pharmacy company Valisure found that NDMA was present in 16 batches of metformin manufactured by 11 different drug companies. The levels were found to be 16 times higher than the acceptable daily limit of NDMA.

Metformin is currently used to control blood sugar levels in people with type 2 diabetes. As a result of the elevated levels of NDMA, Valisure is pressing regulators and manufacturers to initiate recalls of the affected medications. No recalls have been initiated yet, and the U.S. Food and Drug Administration has conducted its own testing and research concerning metformin.

If you or someone you love currently takes metformin, don’t take stop taking it without speaking to your doctor first. If the drug eventually becomes recalled, speak with your doctor about potential alternative medications you can take that don’t have the same elevated risk of cancer.

Finally, if you or someone you love was injured by a dangerous medication, it’s important to get experienced and dedicated legal representation on your side. The drug injury attorneys at Ferrer, Poirot & Wansbrough are here to help you maximize your chances of a full financial recovery. Contact us today for a free consultation.